Source: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=56&amp;showFR=1
Timestamp: 2019-04-25 07:55:05+00:00

Document:
§ 56.103 - Circumstances in which IRB review is required.
§ 56.104 - Exemptions from IRB requirement.
§ 56.105 - Waiver of IRB requirement.
§ 56.107 - IRB membership.
§ 56.108 - IRB functions and operations.
§ 56.109 - IRB review of research.
§ 56.110 - Expedited review procedures for certain kinds of research involving no more than minimal risk, and for minor changes in approved research.
§ 56.111 - Criteria for IRB approval of research.
§ 56.112 - Review by institution.
§ 56.113 - Suspension or termination of IRB approval of research.
§ 56.114 - Cooperative research.
§ 56.115 - IRB records.
§ 56.120 - Lesser administrative actions.
§ 56.121 - Disqualification of an IRB or an institution.
§ 56.122 - Public disclosure of information regarding revocation.
§ 56.123 - Reinstatement of an IRB or an institution.
§ 56.124 - Actions alternative or additional to disqualification.
Authority: 21 U.S.C. 321, 343, 346, 346a, 348, 350a, 350b, 351, 352, 353, 355, 360, 360c-360f, 360h, 360i, 360j, 360hh-360ss, 371, 379e, 381; 42 U.S.C. 216, 241, 262.
Source: 46 FR 8975, Jan. 27, 1981, unless otherwise noted.

References: § 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56

§ 56